Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial

Published:2019-06 Issue:10191 Volume:393 Page:2624-2634
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Snider Cynthia J,Zaman Khalequ,Estivariz Concepcion F,Yunus Mohammad,Weldon William C,Wannemuehler Kathleen A,Oberste M Steven,Pallansch Mark A,Wassilak Steven GF,Bari Tajul Islam A,Anand Abhijeet

Funder

Canadian Dairy Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Eradicating polio;Adams;Science,2015

2. Policy. OPV cessation— the final step to a “polio-free” world;Aylward;Science,2005

3. Meeting of the Strategic Advisory Group of Experts on immunization, April 2013—conclusions and recommendations;Wkly Epidemiol Rec,2013

4. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial;Anand;Vaccine,2015

5. Priming after a fractional dose of inactivated poliovirus vaccine;Resik;N Engl J Med,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enteroviruses: epidemic potential, challenges and opportunities with vaccines;Journal of Biomedical Science;2024-07-15

2. Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria;Vaccine: X;2024-06

3. February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines;Pediatrics;2024-05-02

4. Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia;BMC Global and Public Health;2024-03-06

5. Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance;Pathogens;2024-03-04